Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

583 results

The future is now: QFR and RMS to optimise coronary artery disease patient management

20 May 2025 – From EuroPCR 2025

See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...

The future is now: QFR and RMS to optimise coronary artery disease patient management

Strategic decision in stent failure

20 May 2025 – From EuroPCR 2025

Explore strategic decision-making in cases of stent failure in this session presenting complex clinical scenarios. Through detailed case analyses, including challenging left main trifurcation lesions and NSTEMI in the presence of chronic total occlusions, discover treatment approaches and key learnings to optimize patient outcomes.

Strategic decision in stent failure

DCB-PCI in de novo lesions

20 May 2025 – From EuroPCR 2025

Evaluate the role of drug-coated balloon (DCB) angioplasty in de novo coronary lesions with a focus on vessel diameter effects, comparisons to drug-eluting stents for small non-complex lesions, management of unstented dissections, high bleeding risk scenarios, and optimal dual antiplatelet therapy durations.

DCB-PCI in de novo lesions

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

20 May 2025 – From EuroPCR 2025

Explore how bifurcation treatment is evolving with the integration of drug-coated balloons, angio-based FFR, and advanced side branch optimisation. This EuroPCR 2025 session highlights why DCB is gaining traction for bifurcation lesions and introduces the upcoming EBC-DCB trial comparing a stepwise DCB strategy to provisional DES...

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

Intracoronary value for PCI optimisation

20 May 2025 – From EuroPCR 2025

Optimize your PCI strategies with intracoronary insights in this session highlighting plaque stabilization, coronary stent optimization under pressure, and the critical role of intravascular imaging beyond angiography. Learn management approaches for traumatic coronary artery dissection and explore diagnosis of delayed stent fracture using enhanced stent visualization...

Intracoronary value for PCI optimisation

PCR's Got Talent Round 1 - Session 2

20 May 2025 – From EuroPCR 2025

Join the dynamic PCR's Got Talent Round 1 - Session 2 featuring cutting-edge research and innovations in interventional cardiology. Highlights include complex CTO PCI strategies, valve comparisons in TAVI for small annuli, PFO closure outcomes, long-term PCI durability, CT-guided robotic PCI, pacemaker prediction post-TAVI, and much...

PCR's Got Talent Round 1 - Session 2

New solutions for old problems

19 May 2025 – From EuroPCR 2025

Discover new solutions addressing persistent cardiovascular challenges, including novel diagnostic systems, vascular closure devices, specialized transcatheter closure technologies, and innovative stent-graft systems.

New solutions for old problems

Advances in the development of drug-coated balloon

22 May 2025 – From EuroPCR 2025

Join Florim Cuculi and Rony Mathew at this EuroPCR 2025 roundtable to assess the evolution of drug-coated balloons (DCBs) and their role in daily practice.

DCBs offer a compelling alternative to stent implantation in selected cases. However, they are not interchangeable—each is built using different drugs, carriers,...

Advances in the development of drug-coated balloon

Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in acute coronary syndrome

21 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 interview, Davide Capodanno and Woong Chol Kang discuss antithrombotic therapy in patients with acute coronary syndromes, focusing on the design and outcomes of the 4D-ACS trial. They describe the patient population enrolled in the study and introduce the two de-escalation strategies investigated:...

Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after DCS insertion in ACS